Gregory Scott Duncan, CHIEF EXECUTIVE OFFICER at Virios Therapeutics, Inc. (VIRI), bought 7,500 shares at $4.52 ($34K) on 2022-05-23, disclosed to the SEC on 2022-05-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VIRI | BUY | 2021-04-07 | $2K | — | Filing → |
| VIRI | BUY | 2021-04-06 | $193K | — | Filing → |